![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » NEUROSCIENCE THERAPY CORP. RECEIVES DISTRIBUTION RIGHTS IN CENTRAL AND SOUTH AMERICA
NEUROSCIENCE THERAPY CORP. RECEIVES DISTRIBUTION RIGHTS IN CENTRAL AND SOUTH AMERICA
April 13, 2006
Neuroscience Therapy Corp. announced today that it now holds the exclusive distribution rights in Central and South America for its leading product P-Stim, a patent protected medical device used to treat a variety of acute and chronic pain conditions.
Yahoo News (http://biz.yahoo.com/prnews/060413/to142.html?.v=27)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct